JP2008539228A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539228A5 JP2008539228A5 JP2008508773A JP2008508773A JP2008539228A5 JP 2008539228 A5 JP2008539228 A5 JP 2008539228A5 JP 2008508773 A JP2008508773 A JP 2008508773A JP 2008508773 A JP2008508773 A JP 2008508773A JP 2008539228 A5 JP2008539228 A5 JP 2008539228A5
- Authority
- JP
- Japan
- Prior art keywords
- intraepithelial neoplasia
- anogenital
- therapeutic agent
- anogenital intraepithelial
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05103447.8 | 2005-04-27 | ||
| EP05103447 | 2005-04-27 | ||
| PCT/NL2006/050099 WO2006115413A2 (en) | 2005-04-27 | 2006-04-25 | Methods and means for the treatment of hpv induced intraepithelial neoplasias |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008539228A JP2008539228A (ja) | 2008-11-13 |
| JP2008539228A5 true JP2008539228A5 (https=) | 2009-04-02 |
| JP5106384B2 JP5106384B2 (ja) | 2012-12-26 |
Family
ID=35583560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008508773A Expired - Fee Related JP5106384B2 (ja) | 2005-04-27 | 2006-04-25 | Ｈｐｖ誘導性上皮内腫瘍の治療方法及び治療手段 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7807369B2 (https=) |
| EP (2) | EP1874312B1 (https=) |
| JP (1) | JP5106384B2 (https=) |
| CN (1) | CN101189014A (https=) |
| AT (1) | ATE506063T1 (https=) |
| AU (1) | AU2006240561B2 (https=) |
| CA (1) | CA2609927A1 (https=) |
| DE (1) | DE602006021408D1 (https=) |
| ES (1) | ES2363247T3 (https=) |
| WO (1) | WO2006115413A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009012922A (es) * | 2007-05-31 | 2010-07-05 | Academisch Ziekenhuis Leiden H | Vacunacion intradermica de un peptido del virus del papiloma humano. |
| CN102686720B (zh) * | 2009-11-17 | 2013-12-04 | 国立大学法人冈山大学 | 由牙髓细胞向成牙本质细胞的分化诱导方法 |
| EP2508190B1 (en) * | 2009-12-03 | 2021-06-02 | Aureo Co., Ltd. | Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages |
| US20150310003A1 (en) * | 2014-04-28 | 2015-10-29 | Elwha Llc | Methods, systems, and devices for machines and machine states that manage relation data for modification of documents based on various corpora and/or modification data |
| WO2017015504A1 (en) * | 2015-07-21 | 2017-01-26 | Scheibel Steven Frederick | Treatment and prevention of anal conditions |
| ES3055492T3 (en) | 2015-09-16 | 2026-02-12 | Dfb Soria Llc | Delivery of drug nanoparticles and methods of use thereof |
| WO2017083963A1 (en) | 2015-11-18 | 2017-05-26 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyi:c polynucleotide adjuvant and a lipid-based adjuvant |
| CN106632694B (zh) * | 2017-01-24 | 2021-02-12 | 南京益康生物医药有限公司 | 一种重组蛋白及药物组合物与应用 |
| WO2018170196A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
| WO2018170210A1 (en) * | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of vulvar intraepithelial neoplasia (vin) and genital warts using nanoparticles of taxanes |
| RU2682783C2 (ru) * | 2017-06-14 | 2019-03-21 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ лечения цервикальных интраэпителиальных неоплазий i степени, ассоциированных с впч высокого онкогенного риска, с использованием кавитированного раствора панавира |
| EP3765035A4 (en) | 2018-03-16 | 2021-10-27 | DFB Soria, LLC | TOPICAL THERAPY FOR THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) AND COLD CANCER USING TAXANE NANOPARTICLES |
| CN109614613B (zh) | 2018-11-30 | 2020-07-31 | 北京市商汤科技开发有限公司 | 图像的描述语句定位方法及装置、电子设备和存储介质 |
| WO2022036495A1 (en) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Lymphocytes-antigen presenting cells co-stimulators and uses thereof |
| CN111905201A (zh) * | 2020-08-18 | 2020-11-10 | 珠海市索利达医疗器械有限公司 | 一种生殖道hr-hpv治疗设备 |
| CN114409744B (zh) * | 2022-03-29 | 2022-10-04 | 深圳吉诺因生物科技有限公司 | Hpv抗原表位及其鉴定方法、应用 |
| CN119529069B (zh) * | 2025-01-22 | 2025-07-01 | 成都迈科康生物科技有限公司 | 一种抗hpv16和/或hpv18型e2蛋白的抗体、抗体偶联物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ538399A (en) * | 1997-08-05 | 2007-05-31 | Nventa Biopharma Corp | Fusion protein comprising an HPV E7 protein and a stress protein wherein the E7 protein is joined directly to the amino terminus of the stress protein |
| HU229441B1 (en) | 1999-01-08 | 2013-12-30 | 3M Innovative Properties Co | Formulations and methods for treating mucosal associated conditions with an immune response modifier |
| US20030118588A1 (en) | 1999-05-22 | 2003-06-26 | Linda Diehl | Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| NZ523408A (en) * | 2000-06-26 | 2006-02-24 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
| AU2002219711B8 (en) | 2000-12-08 | 2006-03-02 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| EP1288292A1 (en) * | 2001-08-31 | 2003-03-05 | Leids Universitair Medisch Centrum | Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses. |
| GB0105606D0 (en) * | 2001-03-07 | 2001-04-25 | Cantab Pharmaceuticals Res Ltd | Immunogens and vaccines and their preparation and use |
| CA2467723C (en) * | 2001-12-17 | 2011-09-27 | Zymogenetics, Inc. | Method for treating cervical cancer |
| EP1663222A4 (en) * | 2003-09-02 | 2008-05-21 | 3M Innovative Properties Co | METHODS RELATING TO THE TREATMENT OF GIANCES |
| EP1720567A2 (en) * | 2004-02-10 | 2006-11-15 | Innate Pharma | Composition and method for the treatment of carcinoma |
-
2006
- 2006-04-25 CA CA002609927A patent/CA2609927A1/en not_active Abandoned
- 2006-04-25 US US11/912,961 patent/US7807369B2/en not_active Expired - Fee Related
- 2006-04-25 EP EP06733077A patent/EP1874312B1/en not_active Expired - Lifetime
- 2006-04-25 CN CNA2006800185618A patent/CN101189014A/zh active Pending
- 2006-04-25 ES ES06733077T patent/ES2363247T3/es not_active Expired - Lifetime
- 2006-04-25 AU AU2006240561A patent/AU2006240561B2/en not_active Ceased
- 2006-04-25 EP EP10176404.1A patent/EP2289516B1/en not_active Expired - Lifetime
- 2006-04-25 DE DE602006021408T patent/DE602006021408D1/de not_active Expired - Lifetime
- 2006-04-25 WO PCT/NL2006/050099 patent/WO2006115413A2/en not_active Ceased
- 2006-04-25 JP JP2008508773A patent/JP5106384B2/ja not_active Expired - Fee Related
- 2006-04-25 AT AT06733077T patent/ATE506063T1/de not_active IP Right Cessation
-
2010
- 2010-09-10 US US12/879,782 patent/US20110008287A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008539228A5 (https=) | ||
| CN111991556B (zh) | SARS-CoV-2 RBD共轭纳米颗粒疫苗 | |
| Jangra et al. | Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine | |
| AU2010238943B2 (en) | A tuberculosis TB vaccine to prevent reactivation | |
| Raman et al. | Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles | |
| US20180015156A1 (en) | Polymer particles and uses thereof | |
| Tada et al. | Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice | |
| JP2013532971A5 (https=) | ||
| JP2011500073A5 (https=) | ||
| RU2010107207A (ru) | Новые синтетические агонисты tlr9 | |
| WO2005089164A3 (en) | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions | |
| JP2013507907A5 (https=) | ||
| JP2022549791A (ja) | ジフテリア毒素交差反応物質（ｃｒｍ）アミノ酸配列を含むタンパク質粒子及びその使用 | |
| RU2010154605A (ru) | Вакцинная композиция, пригодная при инфекциях hpv и вирусом, и способ ее получения | |
| JP2010532656A5 (https=) | ||
| EP4106803A1 (en) | Propionibacterium acnes prophylactic and therapeutic immune treatment | |
| JP2013535428A (ja) | 呼吸器合胞体ウイルス抗原組成物および方法 | |
| Ingrole et al. | Synthesis and immunogenicity assessment of elastin-like polypeptide-M2e construct as an influenza antigen | |
| Yu et al. | Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71 | |
| JP2014532722A5 (https=) | ||
| Moreno-Mendieta et al. | A novel antigen-carrier system: The Mycobacterium tuberculosis Acr protein carried by raw starch microparticles | |
| JP5106384B2 (ja) | Ｈｐｖ誘導性上皮内腫瘍の治療方法及び治療手段 | |
| Hwang et al. | Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice | |
| Cacciottolo et al. | Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants | |
| Li et al. | Self-assembled nanofibers elicit potent HPV16 E7-specific cellular immunity and abolish established TC-1 graft tumor |